Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome

DENİZ A., ALİKILIÇ D., ÖZTÜRK M., KARACA Ö., Güngör M., KARA B.

Journal of AAPOS, cilt.27, sa.2, ss.110-112, 2023 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 2
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1016/j.jaapos.2022.12.001
  • Dergi Adı: Journal of AAPOS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.110-112
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Opsoclonus-myoclonus-ataxia syndrome (OMAS) in children is most often of paraneoplastic origin, but it can also result from infectious processes, toxic and metabolic disorders, and organic events that cause damage to the brainstem or cerebellum. Post-vaccination OMAS has also been reported. We report the case of a 15-year-old girl who developed OMAS 24 hours after her first dose of mRNA COVID-19 (BioNTech) vaccine.